Artemis Medicare Services Ltd Stock Price Today (NSE: ARTEMISMED)

Artemis Medicare Services Ltd

ARTEMISMEDHospital
270.90+3.30 (+1.23%)
Market Closed

Fundamental Score

...

Artemis Medicare Services Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Artemis Medicare Services Ltd share price today is 270.90, up +1.23% on NSE/BSE as of 2 June 2026. Artemis Medicare Services Ltd (ARTEMISMED) is a Small-cap company in the Hospital sector with a market capitalisation of 4.41K (Cr). The 52-week high for ARTEMISMED share price is 297.50 and the 52-week low is 203.35. At a P/E ratio of 46.29x, ARTEMISMED is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 12.92% and a debt-to-equity ratio of 0.31.

Artemis Medicare Services Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
295.00
Low
235.49
Volume
2.3L
Change
+12.96%

Artemis Medicare Services Ltd share price chart: 12.96% return over the past month. 52-week high ₹297.50, 52-week low ₹203.35.

Artemis Medicare Services Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
285.50285.50273.85277.171.63L (Cr)
288.00295.00282.60283.631.85L (Cr)
284.65292.00280.12287.923.81L (Cr)
278.31279.49270.70273.0366.15K (Cr)
283.40284.79276.28279.311.13L (Cr)
274.30281.20262.64279.531.64L (Cr)
271.10280.78271.10275.221.04L (Cr)
280.00280.00271.00272.461.68L (Cr)
279.30285.58276.10279.802.07L (Cr)
279.00282.00272.41277.421.74L (Cr)

Artemis Medicare Services Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
244.13295.00243.01277.17+13.53%
207.50247.10207.50244.13+17.65%
234.12237.35203.35205.51-12.22%
245.00249.00210.06239.90-2.08%
271.95280.60221.00247.95-8.83%
287.90295.00261.55271.05-5.85%
247.56297.50240.35285.46+15.31%
234.16254.60222.05247.56+5.72%
219.10251.77219.10234.18+6.88%
239.05256.60217.83218.98-8.40%
254.55265.25226.00239.05-6.09%
279.00280.80242.00254.50-8.78%

AI Research Briefing

Powered by Gemini · 2026-04-09

Small-cap hospital chain with aggressive expansion plans faces high promoter pledging and liquidity risk.

Research Confidence
6.0/10Moderate
MICRO-CAP DARK HORSERecent recovery after hitting 52-week low, indicating potential consolidation.P/E of 46.29x vs. Industry P/E of 52.84x suggests relative undervaluation.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Artemis Medicare Services Ltd. experienced a volatile period. On March 30, 2026, the stock fell to a 52-week low of However, it rebounded strongly on April 1, 2026, with a 7.87% surge, closing at The week closed on April 3, 2026, at , a 3.25% gain for the week, outperforming the Sensex. The trading window closed on April 1, 2026, in anticipation of Q4 results.

CORE STORY (THE REAL GAME)

Artemis is a small-cap hospital chain attempting aggressive expansion while managing promoter pledging risk. The market is trying to figure out if they can scale without imploding.

Why Now
  • Raipur facility commissioning in April 2026
  • Q3 FY26 showed strong profitability surge
  • Technical rebound from 52-week low
Potential Catalysts
  • Successful commissioning and ramp-up of Raipur hospital
  • Significant order wins or contracts
  • Reduction in promoter pledging
Key Risks
  • High promoter pledging (44.53%)
  • Small-cap liquidity risk
  • Expansion execution risk
Institutional Activity

FII increased stake significantly (Δ 12.24%), while DII decreased (Δ -1.41%), indicating mixed institutional sentiment.

Macro Context

Potential increase in hospital bills and medicine costs due to geopolitical tensions (Iran War).

Order Book / Expansion

Raipur facility commissioning scheduled for April 2026.

Cash Flow Quality

Free Cash Flow 5Y: ₹33.75 Cr, indicating limited cash generation.

3–6 Month Outlook

Next 3-6 months hinge on successful Raipur facility launch and Q4 results. Monitor promoter pledging and liquidity closely.

Primary Thesis Risk

Promoter pledging could trigger a collapse if the stock falters.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

12.92%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

14.88%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

13.90%

Average operating profit margin over 5 years

Dividend Yield

0.16%

Annual dividend as % of current share price

Artemis Medicare Services Ltd Valuation Check

Good

Price to Earnings (P/E)

46.29x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

52.84x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

58.43%

% shares held by company founders/management

Good

FII Holding

12.48%

% shares held by foreign institutional investors

Poor

DII Holding

3.35%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

44.53%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

32.80%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

14.96%

Revenue growth vs same quarter last year

Average

Revenue Growth (5-Year CAGR)

10.15%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

31.44%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

32.46%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.31x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

5.31x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

33.75 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Artemis Medicare Services Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ARTEMISMED across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Robust Profit Growth (32.80%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Excellent EPS Growth (31.44% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (32.46% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Interest Coverage (5.31x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹33.75 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (58.43%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Risk Factors

2 factors identified

Premium Valuation Risk (P/E: 46.29x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

High Share Pledging Risk (44.53%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

Artemis Medicare Services Ltd vs Hospital Peers

Peer Comparison - Hospital

Compare Artemis Medicare Services Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
41/100
271
₹4413.98
46.3
Average
12.92%
Average
14.88%
Average
0.3
Excellent
32.46%
Excellent
10.15%
Good
0.16%
69.1/100
993
₹109416.28
77.7
Average
12.72%
Average
14.88%
Average
0.3
Excellent
80.50%
Excellent
46.01%
Excellent
0.13%
50.2/100
8273
₹104825.94
62.7
Average
18.42%
Good
16.64%
Good
0.9
Good
33.72%
Excellent
14.15%
Good
0.26%
55.6/100
961
₹68301.24
67.8
Average
10.13%
Average
11.96%
Average
0.3
Excellent
70.31%
Excellent
10.93%
Good
0.11%
62.2/100
1920
₹39051.19
45.9
Average
24.22%
Excellent
20.75%
Excellent
0.6
Good
43.49%
Excellent
11.88%
Good
0.24%
15.4/100
741
₹34688.15
94.5
Average
8.26%
Poor
10.68%
Average
0.5
Excellent
-7.24%
Poor
-13.71%
Poor
0.75%
61/100
1208
₹33498.00
56.0
Average
16.48%
Good
19.74%
Good
0.3
Excellent
70.15%
Excellent
19.73%
Excellent
0.04%
45.1/100
784
₹27605.54
84.0
Average
18.48%
Good
15.00%
Good
1.4
Average
25.01%
Excellent
22.01%
Excellent
0.00%
51.2/100
480
₹16844.04
145.2
Average
4.76%
Poor
9.99%
Poor
0.5
Good
41.72%
Excellent
26.38%
Excellent
0.00%
54.6/100
1377
₹13410.38
52.8
Average
17.43%
Good
18.69%
Good
0.5
Good
33.66%
Excellent
16.08%
Excellent
0.23%
36.4/100
660
₹10474.40
296.2
Average
5.14%
Poor
8.56%
Poor
1.9
Average
19.34%
Excellent
15.22%
Excellent
0.00%

Artemis Medicare Services Ltd Quarterly Performance

Latest quarterly metrics for ARTEMISMED — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

14.96%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

32.80%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

10.15%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

32.46%

Compounded annual net profit growth over 5 years

Artemis Medicare Services Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ARTEMISMED — calculated from daily price history

57RSI 14
Neutral — RSI 57

Momentum is balanced — neither overbought nor oversold.

SMA 50
244
▲ Price above SMA 50 — Short-term bullish
SMA 200
247
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
229K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Artemis Medicare Services Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Artemis Medicare Services Ltd (ARTEMISMED) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Artemis Medicare Services Ltd

About ARTEMISMED (Artemis Medicare Services Ltd)

Artemis Medicare Services Ltd is a prominent healthcare provider, weaving a tapestry of medical expertise across its network of hospitals. Each facility is a hub of advanced techno...logy and compassionate care, designed to cater to a diverse range of medical needs. From intricate surgical procedures to comprehensive medical management, Artemis hospitals are equipped with state-of-the-art diagnostic tools and treatment modalities. They foster an environment of healing, where patient well-being is at the heart of every endeavor. Artemis remains committed to fostering excellence and setting new standards in the delivery of healthcare services. Beyond the core medical and surgical interventions, Artemis Medicare Services Ltd emphasizes holistic patient care, recognizing the interconnectedness of physical and emotional well-being. Patients and their families benefit from a comprehensive suite of support services. This includes specialized programs like emotional support and counseling, nutritional guidance, and even childcare facilities, easing the burden on families during challenging times. Multilingual medical interpreters facilitate effective communication for international patients, ensuring a seamless and comfortable experience. Artemis proactively promotes a patient-centric approach by actively involving patients and their families in the decision-making process through advisory councils. The Artemis Medicare Services Ltd commitment to excellence is further demonstrated through cutting-edge initiatives like telemedicine and patient portals. These innovations improve accessibility to healthcare. Patients can effortlessly schedule appointments, access their medical records, and communicate with healthcare professionals remotely. The focus on continuous innovation allows Artemis to extend its reach and cater to a growing number of patients across India and internationally. Artemis Medicare strives to provide accessible, affordable, and high-quality healthcare to all.

Company Details

Symbol:ARTEMISMED
Industry:Hospital
Sector:Hospital

Key Leadership

Dr. Devlina Chakravarty DMRD, DNB, M.D., Radiology
CEO, MD & Executive Director
Mr. Sanjiv Kumar Kothari
Chief Financial Officer
Ms. Poonam Makkar
Company Secretary & Compliance Officer

Corporate Events

Recent
Ex-Dividend Date

ARTEMISMED Share Price: Frequently Asked Questions

What is the current share price of Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd (ARTEMISMED) trades at ₹270.90 on NSE and BSE. Market cap ₹4.41K (Cr). Educational data only.

What is the P/E ratio of Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd has a P/E of 46.29x vs industry average 52.84x.

What is the Bull Run score for Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd has a Bull Run score of 41/100 based on 25+ financial parameters.

Does Artemis Medicare Services Ltd pay dividends?

Artemis Medicare Services Ltd has a dividend yield of 0.16%. Past dividends don't guarantee future payments.

What is the ROE of Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd has ROE of 12.92%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd has debt-to-equity of 0.31.

Is Artemis Medicare Services Ltd a good investment?

Bull Run gives Artemis Medicare Services Ltd a score of 41/100. This is not investment advice — consult a SEBI-registered advisor.